Norwegian Prima Legionnaires’ Disease Investigation – May and July 2026

Introduction

Norwegian Cruise Line is working with the US Centers for Disease Control and Prevention after three passengers who sailed aboard Norwegian Prima in May and July 2026 were diagnosed with Legionnaires’ disease. The source of the exposure had not been established when the cruise line issued a notice to guests and travel partners on September 1.

The investigation is examining whether the passengers may have encountered Legionella bacteria through water-related systems aboard the ship or through another source. The available report does not establish that the ship was the source of the illness, and the diagnosis of three passengers does not by itself identify an outbreak on a particular voyage.

Reported Diagnoses

The report refers to three passengers who sailed aboard Norwegian Prima in May and July and were later diagnosed with Legionnaires’ disease. It does not identify the passengers, the voyages they took, the ports they visited, the date symptoms began, or where the diagnoses were made.

Legionnaires’ disease is a serious form of pneumonia caused by Legionella bacteria. The available report does not provide individual medical details, the severity of the reported illnesses, or whether any passenger required hospital treatment. Norwegian Cruise Line noted that most people who develop the disease recover with appropriate medical treatment, but the source account does not report the outcome for these three passengers.

Norwegian Cruise Line Notice

Norwegian Cruise Line issued information to guests and travel partners on September 1 as a precaution while the investigation continued. The company said that passenger health and safety were priorities and that it was working with the CDC.

The notice did not identify a confirmed source of exposure. It also did not state whether the three passengers travelled together, were on the same voyage, or encountered the same water system. Those details are important because a diagnosis after a cruise does not, without further evidence, prove that exposure occurred aboard the vessel.

Water-System Testing

As part of the investigation, Norwegian Cruise Line tested water-related equipment and fixtures aboard Norwegian Prima. The reported testing included hot tubs, showers and faucets. All results received by the time of reporting were negative, with additional testing planned.

A negative result from testing completed to date does not identify the source of the exposure or close the investigation. The available report does not disclose the testing methods, the number of samples collected, the dates of testing, or whether any other onboard water systems were examined.

The reports also do not state whether the ship was subject to any sanitation measure, temporary closure of a facility, itinerary change, or passenger notification beyond the September 1 notice. No such operational disruption was identified in the available account.

Health Investigation

The CDC’s involvement indicates that the reported diagnoses were being assessed with public-health authorities. The available information does not provide a final epidemiological conclusion, a confirmed exposure pathway, or a finding that Norwegian Prima or any particular facility caused the illnesses.

It is therefore necessary to separate the confirmed diagnoses reported by the source from the unresolved question of where exposure occurred. Further information would need to come from Norwegian Cruise Line, the CDC, the affected passengers, or another competent health authority.

Voyage Information

The affected passengers sailed aboard Norwegian Prima during voyages in May and July 2026. The available report does not identify their departure ports, itineraries, accommodation areas, or the dates on which they disembarked. It also does not say whether the three passengers were exposed during the same sailing or on separate voyages.

Information Not Reported

The source account does not report the names or ages of the passengers, their medical outcomes, the precise date of each diagnosis, the location of exposure, or the particular voyage associated with each case. It also does not provide final testing results, a confirmed source, a CDC conclusion, or details of any remedial action beyond the testing described.

• Ship: Norwegian Prima
• Incident period: May and July 2026; notice issued September 1, 2026
• Location: Aboard Norwegian Prima or another exposure location not established
• Incident type: Reported Legionnaires’ disease diagnoses and health investigation
• Reported passengers diagnosed: Three
• Reported deaths: None
• Reported crew cases: None reported

Operational Outcome

Norwegian Prima remained the subject of a health investigation after three passengers were diagnosed with Legionnaires’ disease following May and July voyages. Norwegian Cruise Line tested selected water-related equipment, reported negative results received to date, and planned further testing in cooperation with the CDC. The source of exposure and the final public-health outcome remained unreported.